Supply for the drugs hasnt always kept up with demand
A major issue with clinically approved GLP-1R agonists like liraglutide and semaglutide is that they cause nausea and vomiting, which hampers patient compliance [3, 57]
Keep it in your carry-on with the ice packs
Clinical studies have shown Tirzepatide's remarkable ability to facilitate significant weight loss, improve blood sugar levels, and boost overall metabolic health, making it a promising option for individuals seeking comprehensive weight management
Additionally, genetic mutations like MTHFR can impact methylation and detox pathways
Who Qualifies for Weight Loss Medications Typically, FDA-approved weight loss medications are prescribed to adults with a BMI of 30 or above, or those with a BMI over 27 who have a weight-related health condition like type 2 diabetes or hypertension